Multiplex Pathogen Identification Panels for Infectious Disease - MEDICAID - KENTUCKY (Revised)
Summary
Humana Kentucky Medicaid revised its multiplex pathogen identification panel policy effective 06/29/2026, establishing new coverage criteria for infectious disease testing including respiratory panels, vaginal bacterial vaginosis tests, tropical fever panels, and cell-free DNA metagenomic sequencing. Prior authorization is now required for BD MAX Vaginal Panel (81514), Karius Test (0152U), and Bridge Women's Health Infectious Disease Detection Test (0330U). Several tests including NeXGen Fungal/AFB NGS (0531U), Johns Hopkins Metagenomic NGS (0323U), BIOTIA-ID Urine NGS (0590U), and Taq Array Card UTI Panel (0593U) are explicitly non-covered.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.